Page last updated: 2024-10-24

chetomin and 2019 Novel Coronavirus Disease

chetomin has been researched along with 2019 Novel Coronavirus Disease in 1 studies

chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.

Research Excerpts

ExcerptRelevanceReference
" The physicochemical and pharmacokinetic features of chetomin were also predicted, and the oral bioavailability of chetomin was demonstrated."1.91Chetomin, a SARS-CoV-2 3C-like Protease (3CL ( Abdeljawaad, KAA; Abdelrahman, AHM; Gabr, GA; Hegazy, MF; Ibrahim, MAA; Mohamed, DEM; Naeem, MA; Paré, PW; Shawky, AM; Sidhom, PA; Soliman, MES, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ibrahim, MAA1
Abdelrahman, AHM1
Mohamed, DEM1
Abdeljawaad, KAA1
Naeem, MA1
Gabr, GA1
Shawky, AM1
Soliman, MES1
Sidhom, PA1
Paré, PW1
Hegazy, MF1

Other Studies

1 other study available for chetomin and 2019 Novel Coronavirus Disease

ArticleYear
Chetomin, a SARS-CoV-2 3C-like Protease (3CL
    Viruses, 2023, 01-15, Volume: 15, Issue:1

    Topics: Antiviral Agents; COVID-19; Cysteine Endopeptidases; Humans; Molecular Docking Simulation; Molecular

2023